1. Home
  2. FLNA vs SCOR Comparison

FLNA vs SCOR Comparison

Compare FLNA & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLNA

Filana Therapeutics Inc. Common Stock

BUY

Current Price

$0.65

Market Cap

61.8M

Sector

Health Care

ML Signal

BUY

Logo comScore Inc.

SCOR

comScore Inc.

BUY

Current Price

$3.18

Market Cap

73.8M

ML Signal

BUY

Company Overview

Basic Information
Metric
FLNA
SCOR
Founded
1998
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
61.8M
73.8M
IPO Year
2000
2007

Fundamental Metrics

Financial Performance
Metric
FLNA
SCOR
Price
$0.65
$3.18
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $6.50
N/A
AVG Volume (30 Days)
★ 702.8K
40.8K
Earning Date
11-11-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 127.37
EPS
N/A
★ N/A
Revenue
$41,119,000.00
★ $403,549,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 1.02
52 Week Low
$0.64
$3.11
52 Week High
$2.03
$9.34

Technical Indicators

Market Signals
Indicator
FLNA
SCOR
Relative Strength Index (RSI) 34.93 28.22
Support Level N/A N/A
Resistance Level $1.05 $7.78
Average True Range (ATR) 0.04 0.40
MACD -0.02 -0.03
Stochastic Oscillator 3.74 11.76

Price Performance

Historical Comparison
FLNA
SCOR

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

Share on Social Networks: